TradeApes scores every US-listed company from its SEC filings — a 0–100 health score and a clear valuation verdict — then puts that analysis on your own holdings, your watchlist, and the stocks you are researching. Earnings reminders, verdict-change alerts, and AI-written research reports keep you ahead of what you own.
Import a spreadsheet from your brokerage or enter positions by hand. Every holding is scored for health, valuation, and risk, and you hear about it when a verdict changes or an earnings date is near.
Look up any stock and get a free score card, or browse a live watchlist.
Every plan includes SEC-backed health scores, valuation verdicts, earnings reminders, and the weekly Sector Leaders newsletter. Upgrade for AI research reports, alerts, and bigger limits.
Import a spreadsheet from your brokerage or add positions by hand, lot by lot. One view of everything you own with health scores, valuation verdicts, gains and losses, and wash-sale windows.
Every company is scored 0–100 across five pillars — financial strength, operating trend, relative value, capital allocation, and risk — straight from its SEC filings, with the findings behind the score in plain English.
Undervalued, Fair Value, Overvalued, or Inconclusive. Our model combines discounted cash flow and peer-multiple approaches and publishes a fair value only when its methods agree — so a verdict is one we stand behind, and "we don't know yet" is an honest answer.
Track up to 10 stocks outside your portfolio. Every ticker gets the same SEC-backed scores, health ratings, and valuation analysis.
Filter stocks by sector, health score, and valuation zone. See the top 10 results ranked by opportunity score.
Email reminders five days and one day before a company you hold or watch reports, and an alert whenever its valuation verdict changes. A Sunday digest rounds up the week.
An analyst-style write-up for any stock: what today's price implies, where the valuation hinges, the catalysts and risks that matter — grounded in the same filing data as the score. 20 reports a month on Pro, 40 on Premium.
Every feature connects to the same SEC-backed analysis. Screen, compare, track, and analyze from one place.
Practical guides on portfolio management, stock screening, valuation, and building a repeatable research process.